Position in IDYA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$9,263,793
+$741,737 QoQ
Shares Held
248,559
-2.8% QoQ
Ownership
0.258%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#53
of 286 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JENNISON ASSOCIATES LLC holds $3,808,452,552 across 46 Biotechnology names. IDYA ranks #39 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,998,530 | $1,489,459,806 | |
| 2 | ARGX |
Argenx SE
|
226,200 | $209,861,574 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
4,481,964 | $158,616,705 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
960,619 | $146,801,794 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
1,151,681 | $141,173,056 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,358,587 | $129,722,285 | |
| 7 | IMVT |
Immunovant, Inc.
|
3,310,238 | $127,543,470 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
4,219,058 | $110,623,700 |
All Filings in IDYA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,263,793 | 248,559 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $8,522,056 | 255,764 | Shares | Defined | 2026-05-06 | |
| 2025-03-31 | $8,627,149 | 526,688 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $25,048,145 | 974,636 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $30,801,386 | 972,266 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $14,425,364 | 410,862 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $11,244,206 | 256,249 | Shares | Defined | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||